(BOSTON: Thursday, February 8, 2024) – Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) will award up to US$1.8 million to biotechnology company, Visby Medical, to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback